Just because a blood test shows your bad cholesterol or fat levels went down doesn't mean you're less likely to have a heart attack—only big, long-term studies with real patients can prove that.
Evidence from Studies
Supporting (2)
Community contributions welcome
Extent of Low-density Lipoprotein Cholesterol Reduction and All-cause and Cardiovascular Mortality Benefit: A Systematic Review and Meta-analysis
Lowering bad cholesterol (LDL) helps people live longer, but lowering it even more doesn’t always help them live much longer—so just seeing numbers go down isn’t enough; we need to check if people actually have fewer heart attacks or live longer.
Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials.
This study looked at real patient trials and found that lowering LDL cholesterol with medications actually reduces heart attacks and strokes — but only because it used high-quality, long-term randomized trials. So yes, you need those trials to prove biomarker changes lead to real health benefits.
Contradicting (1)
Community contributions welcome
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.
This study found that when people take medicines that lower 'bad' cholesterol (LDL), they have fewer heart attacks and strokes — proving that lowering cholesterol isn't just a lab number change, it actually helps people stay healthier.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.